CNR1 and fatty liver disease: In mice fed excessive alcohol and patients with alcohol-related liver cirrhosis, CB1 levels significantly increase [84,85]; at the same time, CB1 deficiency or the use of CB1 antagonists can inhibit HSC activation, significantly reducing alcohol-induced hepatic steatosis [86].